Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1425 - 1432 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC5823 | CYN 154806 |
|
Potent and selective somatostatin sst2 receptor antagonist. pIC50 values are 8.58, 5.41, 6.07, 5.76 and 6.48 for human recombinant sst2, sst1, sst3, sst4 and sst5 receptors respectively.
|
|
| BCC5824 | BIM 23056 |
|
Somatostatin receptor ligand (K<sub>i</sub> values are 142, > 1000, 10.8, 16.6 and 5.7 nM for human cloned sst<sub>1 - 5</sub> receptors respectively). Behaves as an antagonist on SRIF14-induced [<sup>35</sup>S]-GTP<span class='symbol'>γ</span>S binding at sst<sub>3</sub> and sst<sub>5</sub> receptors (PK<sub>B</sub> values are 6.33 and 5.84 respectively).
|
|
| BCC5825 | Ac2-26 |
|
Annexin/lipocortin 1-mimetic peptide; inhibits leukocyte extravasation. Reduces neutrophil adhesion and emigration, promotes detachment of neutrophils from activated mesenteric endothelium and accelerates epithelial wound repair after induced colonic injury in mice in vivo. Anti-inflammatory.
|
|
| BCC5826 | Ac2-12 |
|
Annexin/lipocortin 1-mimetic peptide; inhibits leukocyte extravasation. Reduces neutrophil adhesion and emigration, and promotes detachment of neutrophils from activated mesenteric endothelium in mice in vivo.
|
|
| BCC5827 | Glucagon-like peptide 1 (1-37) (human, rat) |
|
Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on food intake in rats and does not enhance pancreatic insulin secretion. However it induces insulin expression in intestinal epithelial cells, which can restore glucose homeostasis when implanted into diabetic mice.
|
|
| BCC5828 | MLCK inhibitor peptide 18 |
|
Selective competitive inhibitor of myosin light chain kinase (IC50 = 50 nM). Displays 4000-fold selectivity over CaM kinase II and does not inhibit PKA. Cell permeable.
|
|
| BCC5829 | Neuropeptide SF (human) |
|
Endogenous antiopioid peptide, implicated in pain modulation and endocrine functions. Potently activates the orphan G-protein-coupled receptor HLWAR77 (NPFF2) (EC50 = 0.39 nM).
|
|
| BCC5830 | PKC fragment (530-558) |
|
Potent activator of protein kinase C (Ka ~ 10 mM); corresponds to residues 530-558 of the catalytic domain of PKC.
|
|